General cellular iron homeostasis

General cellular iron homeostasis is the physiological process by which cells maintain a precise balance of iron, an essential element for life that is also potentially toxic (StatPearls, NBK448027). Iron serves as a critical cofactor for numerous enzymes involved in oxygen transport, DNA synthesis, and energy metabolism (Nature Reviews Molecular Cell Biology, 2012). However, its ability to participate in Fenton chemistry means that excess 'labile' iron can generate reactive oxygen species and cause cellular damage (PubMed, 30104444). This homeostasis is maintained through a sophisticated network of proteins, including Transferrin Receptor 1 for uptake, Ferritin for storage, and Ferroportin for export (UniProt, P81172). Systemic regulation is primarily governed by the liver-derived hormone hepcidin, which controls iron flux by inducing the degradation of ferroportin (Nature Reviews Molecular Cell Biology, 2012). Clinical disorders arise when this balance is disrupted, leading to either iron deficiency (anemia) or iron overload (hemochromatosis), both of which have profound systemic effects (Mayo Clinic, 2023). Therapeutic strategies involve the use of iron chelators like Deferoxamine to manage overload and iron salts or complexes for deficiency (PubMed, 30104444). Emerging therapies like hepcidin mimetics (e.g., Rusfertide) are being developed to treat disorders of iron distribution and polycythemia vera (PMC, 8915312). Because iron is vital for both host and pathogen survival, as well as cancer cell proliferation, modulating this system requires precise control to avoid systemic toxicity (PubMed, 30104444).

Other names

Iron metabolismCellular iron regulationSystemic iron homeostasisIron-responsive element/iron regulatory protein (IRE/IRP) system

Drugs modulate iron levels by chelating excess iron, supplementing deficient iron, or regulating the hepcidin-ferroportin axis to control systemic and cellular iron flux.